Immix Biopharma, Inc.
IMMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001873835
No open-market purchases or sales by Immix Biopharma, Inc. insiders were filed in the last 90 days; 109 institutions reported holding it in 13F filings for Q2 2026, worth $579.6M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Immix Biopharma, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 23 | 31 | +8 |
| Shares | 2.26M | 2.77M | +503.7K (+22.3%) |
| Value | $4.68M | $5.78M | +$1.10M (+23.5%) |
New holders (12)
Institutions that held Immix Biopharma, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 89,798 | $187.7K | 0.00% |
| United Capital Financial Advisers, LLC | 70,682 | $147.7K | 0.00% |
| Imprint Wealth LLC | 67,423 | $140.9K | 0.45% |
| Marshall Wace, LLP | 55,035 | $115.0K | 0.00% |
| XTX Topco Ltd | 35,153 | $73.5K | 0.00% |
| Renaissance Technologies LLC | 21,500 | $44.9K | 0.00% |
| Jane Street Group, LLC | 14,970 | $31.3K | 0.00% |
| CIBC Private Wealth Group, LLC | 10,000 | $20.9K | 0.00% |
| Snowden Capital Advisors LLC | 10,000 | $20.9K | 0.00% |
| MAI Capital Management | 2,000 | $4.18K | 0.00% |
| Citigroup Inc | 35 | $73 | 0.00% |
| SRS Capital Advisors, Inc. | 34 | $71 | 0.00% |
Sold out (4)
Institutions that held Immix Biopharma, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Virtu Financial LLC | 17,846 | $37.0K |
| Royal Bank of Canada | 11,168 | $23.0K |
| Raymond James Financial Inc | 525 | $1.09K |
| Tower Research Capital LLC (TRC) | 131 | $271 |